Collegium Pharmaceutical
COLL
COLL
198 hedge funds and large institutions have $936M invested in Collegium Pharmaceutical in 2023 Q1 according to their latest regulatory filings, with 47 funds opening new positions, 66 increasing their positions, 63 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
7.07% more ownership
Funds ownership: 107.55% → 114.62% (+7.1%)
5% more repeat investments, than reductions
Existing positions increased: 66 | Existing positions reduced: 63
94% less call options, than puts
Call options by funds: $175K | Put options by funds: $3.15M
Holders
198
Holding in Top 10
3
Calls
$175K
Puts
$3.15M
Top Buyers
| 1 | +$13M | |
| 2 | +$8.34M | |
| 3 | +$7.51M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$6.55M |
| 5 |
Morgan Stanley
New York
|
+$5.99M |
Top Sellers
| 1 | -$6.12M | |
| 2 | -$4.87M | |
| 3 | -$4.41M | |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
-$3.89M |
| 5 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$3.6M |